Sun Pharma acquires Organon in $11.75B overseas deal

Sun Pharma acquires Organon in $11.75B overseas deal — Sun Pharma has acquired Organon in a landmark deal worth $11.75 billion, marking the largest overseas acquisition by an Indian pharma company. The move significantly expands Sun Pharma’s global footprint and generic portfolio. The deal is expected to be accretive to earnings post-integration.

📊 STOCKS: SUNPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #MergersAndAcquisitions